Quadruplex real-time PCR for rapid detection of human alphaherpesviruses.
Herpesviridae Infections
/ diagnosis
Herpesvirus 1, Human
/ genetics
Herpesvirus 2, Human
/ genetics
Humans
Molecular Diagnostic Techniques
/ methods
Multiplex Polymerase Chain Reaction
/ methods
Real-Time Polymerase Chain Reaction
/ methods
Sensitivity and Specificity
Time Factors
Varicellovirus
/ genetics
DNA
Human herpesvirus
Simultaneous detection
Journal
Medical microbiology and immunology
ISSN: 1432-1831
Titre abrégé: Med Microbiol Immunol
Pays: Germany
ID NLM: 0314524
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
14
11
2018
accepted:
14
01
2019
pubmed:
27
1
2019
medline:
23
4
2019
entrez:
26
1
2019
Statut:
ppublish
Résumé
Infections with the herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) as well as with the varicella-zoster virus (VZV) may take a serious course. Thus, rapid and reliable detection of these alphaherpesviruses is urgently needed. For this, we established a qualitative quadruplex real-time polymerase chain reaction (PCR) covering HSV-1, HSV-2, VZV and endogenous human glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The PCR was validated with quality assessment samples and pre-characterized clinical samples including swabs, blood and cerebrospinal as well as respiratory fluids. For comparison, nucleic acids (NA) of selected samples were extracted manually and automatically. The protocol takes approx. 90 min, starting with the preparation of NA until the report of results. The oligonucleotide and hydrolysis probe sequences specifically detect and distinguish HSV-1 (530 nm), HSV-2 (705 nm) and VZV (560 nm) DNA. The detection limit was estimated with 100-500 copies/ml HSV-1 and HSV-2/VZV, respectively. All quality assessment samples as well as all the patient samples were classified correctly. Parallel detection of GAPDH (670 nm) DNA was implemented to demonstrate correct sampling, but was uncertain in case of swabs. To this end, alphaherpesvirus-free human DNA was also added directly into the mastermix to exclude PCR inhibition. The established protocol for parallel detection and differentiation of alphaherpesviruses is fast, highly specific as well as rather sensitive. It will facilitate HSV-1/2 and VZV diagnostics and may be further improved by opening the 670 nm channel for a combined extraction and PCR inhibition control.
Identifiants
pubmed: 30680459
doi: 10.1007/s00430-019-00580-2
pii: 10.1007/s00430-019-00580-2
doi:
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
197-204Références
J Clin Microbiol. 1999 Nov;37(11):3634-43
pubmed: 10523566
J Clin Virol. 1999 Sep;14(1):31-6
pubmed: 10548128
J Virol. 1999 Dec;73(12):10514-8
pubmed: 10559370
J Clin Microbiol. 2000 Feb;38(2):795-9
pubmed: 10655387
J Clin Virol. 2000 Jun;17(1):31-6
pubmed: 10814936
J Clin Microbiol. 2000 Aug;38(8):3116-8
pubmed: 10921993
J Clin Microbiol. 2000 Sep;38(9):3187-9
pubmed: 10970354
Lancet. 2001 May 12;357(9267):1513-8
pubmed: 11377626
Vaccine. 2001 Oct 12;20(1-2):121-4
pubmed: 11567755
BMC Microbiol. 2002 Jun 09;2:12
pubmed: 12069697
J Clin Virol. 2002 Jul;25 Suppl 1:S45-51
pubmed: 12091081
Postgrad Med J. 2002 Oct;78(924):575-83
pubmed: 12415078
J Clin Virol. 2003 Jan;26(1):85-93
pubmed: 12589838
Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):764-7
pubmed: 14605937
Sex Transm Dis. 2004 Jun;31(6):331-6
pubmed: 15167640
BMC Infect Dis. 2006 Jun 24;6:104
pubmed: 16796763
Med Microbiol Immunol. 2007 Jun;196(2):89-94
pubmed: 17165093
Med Microbiol Immunol. 2007 Jun;196(2):95-102
pubmed: 17180380
J Clin Microbiol. 2007 Mar;45(3):897-901
pubmed: 17229868
Am J Transplant. 2007 Apr;7(4):741-7
pubmed: 17391119
J Mol Diagn. 2009 Mar;11(2):93-101
pubmed: 19196999
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Biotechniques. 2009 Jun;46(7):519-24
pubmed: 19594451
PLoS One. 2011 Feb 09;6(2):e16142
pubmed: 21347398
Euro Surveill. 2011 Nov 03;16(44):null
pubmed: 22085620
Antivir Chem Chemother. 2013 Jan 23;23(3):93-101
pubmed: 23343513
Int J Infect Dis. 2013 Jul;17(7):e529-34
pubmed: 23566589
Pediatrics. 2014 Jul;134(1):135-54
pubmed: 24982109
J Virol Methods. 2014 Oct;207:133-7
pubmed: 25034126
J Clin Microbiol. 2014 Dec;52(12):4375-6
pubmed: 25275002
J Gen Virol. 2015 Jul;96(Pt 7):1581-602
pubmed: 25794504
J Clin Microbiol. 2015 Jun;53(6):1921-6
pubmed: 25878344
J Virol Methods. 2016 Mar;229:16-23
pubmed: 26711555
Eur J Clin Microbiol Infect Dis. 2016 May;35(5):723-34
pubmed: 26873382
J Virol. 1986 Feb;57(2):446-55
pubmed: 3003377